Topic
Tyrosine Kinase Inhibitor (TKI)
7 Podcasts • 3 Courses on BackTable
Episode # 58 • 05 May 2026
Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options are available for second-line therapy? In this episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi explore the uncertain landscape of second-line treatment after first-line immunotherapy, such as atezolizumab and bevacizumab or the STRIDE regimen, including practical considerations for choosing which second-line therapy to use.
More on Tyrosine Kinase Inhibitor (TKI)
Loading recent podcasts…
Tumor Board # 58
May 4, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
Urology # 221
Mar 17, 2025
with Dr. Sumanta Pal, Dr. Aditya Bagrodia
Sharpen your approach to high-risk renal cell carcinoma (RCC). In this episode of BackTable Urology, guest Dr. Sumanta...
1,400+ listens
Tumor Board # 3
Jan 16, 2025
with Dr. Lingling Du, Dr. Jonathan Mizrahi, Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Tyler Sandow
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative...
2,200+ listens
Vascular & IR # 233
Aug 11, 2022
with Dr. Jack Jennings, Dr. Jacob Fleming
In this episode, host Dr. Jacob Fleming interviews Dr. Jack Jennings about cryoablation, multidisciplinary care, and...
4,300+ listens
Tumor Board # 57
Apr 27, 2026
with Dr. Lingling Du, Dr. Craig Lockhart, Dr. Jonathan Mizrahi
Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In...
Vascular & IR # 513
Jan 30, 2025
with Dr. Lingling Du, Dr. Jonathan Mizrahi, Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Tyler Sandow
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative...
1,700+ listens
Urology # 56
Sep 20, 2022
with Dr. Rana McKay, Dr. Karim Bensalah, Dr. Aditya Bagrodia
In this episode of BackTable Urology, Dr. Aditya Bagrodia speaks with urologist Dr. Karim Bensalah from the...
2,000+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.